Oragenics terminates ATM program, appoints Charles Pope as Chairman

ORAGENICS INC

Terminated Sales Agreement with AGP for ATM program, effective Dec 29, 2022; no further share sales.
In Q4 2022, sold 357,438 shares at avg $0.2024 per share via ATM prior to termination.
Charles Pope appointed Chairman of Board; Frederick Telling steps down as Chairman but remains independent director.

item 1.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

ORAGENICS INC terminated Sales Agreement with A.G.P./Alliance Global Partners (effective 2022-12-19).

Action: termination
Agreement: atm program
Counterparty: A.G.P./Alliance Global Partners
Effective: 2022-12-19

Exact text from the filing

On December 19, 2022, Oragenics, Inc. (the “Company”) sent written notice of termination to A.G.P./Alliance Global Partners ("AGP"), pursuant to the terms of the Company’s Sales Agreement with AGP in connection with the Company’s At-the-Market Sales Program (the “ATM Program”).

View on SEC.gov

Browse all material agreements →

ORAGENICS INC filing history →

Source: SEC EDGAR

accession 0001493152-22-035889

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.